Does METHYLNALTREXONE Cause Neoplasm malignant? 5 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Neoplasm malignant have been filed in association with METHYLNALTREXONE (Relistor). This represents 0.6% of all adverse event reports for METHYLNALTREXONE.
5
Reports of Neoplasm malignant with METHYLNALTREXONE
0.6%
of all METHYLNALTREXONE reports
3
Deaths
1
Hospitalizations
How Dangerous Is Neoplasm malignant From METHYLNALTREXONE?
Of the 5 reports, 3 (60.0%) resulted in death, 1 (20.0%) required hospitalization.
Is Neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for METHYLNALTREXONE. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does METHYLNALTREXONE Cause?
Death (214)
Drug ineffective (148)
Constipation (57)
Abdominal pain (54)
Diarrhoea (41)
Nausea (35)
Abdominal pain upper (33)
Off label use (29)
Vomiting (29)
Pain (26)
What Other Drugs Cause Neoplasm malignant?
RANITIDINE (10,648)
ADALIMUMAB (2,028)
APIXABAN (1,772)
ETANERCEPT (1,616)
METHOTREXATE (1,041)
TOFACITINIB (1,020)
RITUXIMAB (929)
INFLIXIMAB (892)
ABATACEPT (727)
RISANKIZUMAB-RZAA (715)
Which METHYLNALTREXONE Alternatives Have Lower Neoplasm malignant Risk?
METHYLNALTREXONE vs METHYLPHENIDATE
METHYLNALTREXONE vs METHYLPREDNISOLONE
METHYLNALTREXONE vs METHYLPREDNISOLONE ACEPONATE
METHYLNALTREXONE vs METHYLPREDNISOLONE HEMISUCCINATE
METHYLNALTREXONE vs METILDIGOXIN